Steatosis of Liver Clinical Trial
Official title:
Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in Metabolic Dysfunction-associated Steatotic Liver Disease
To assess the diagnostic significance of serum pro-NT in MASLD and ability to differentiate between early and advanced steatosis.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05479721 -
LITMUS Imaging Study
|
||
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Not yet recruiting |
NCT05120557 -
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
|
N/A | |
Completed |
NCT03858920 -
The Liver in the World Trade Center Health Program General Responder Cohort and Controls
|
||
Not yet recruiting |
NCT06373796 -
Ultrasound Index Fat Fraction
|
N/A | |
Withdrawn |
NCT02873507 -
Prediction of Donor Liver Adipose Content by Magnetic Resonance Imaging
|
N/A | |
Recruiting |
NCT04442334 -
The European NAFLD Registry
|
||
Not yet recruiting |
NCT06154096 -
Liver Fat and Glucagon Resistance
|
||
Not yet recruiting |
NCT06373536 -
Comparison of MRI-PDFF to TAEUS FLIP Device to Estimate Liver Fat Fraction in Adults
|
||
Enrolling by invitation |
NCT05676177 -
CT Liver Fat Fraction Quantification
|
N/A | |
Not yet recruiting |
NCT05651724 -
Global Research Initiative for Patients Screening on NASH
|
||
Recruiting |
NCT06021743 -
The Role of Immune Semaphorins in Steatotic Liver Disease and Sepsis
|
||
Completed |
NCT03203486 -
Response of NAFLD Patients to Mediterranean Diet
|
N/A |